Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The cytokines interleukin 27 and interferon-γ promote distinct Treg cell populations required to limit infection-induced pathology.

Immunity | 2012

Interferon-γ (IFN-γ) promotes a population of T-bet(+) CXCR3(+) regulatory T (Treg) cells that limit T helper 1 (Th1) cell-mediated pathology. Our studies demonstrate that interleukin-27 (IL-27) also promoted expression of T-bet and CXCR3 in Treg cells. During infection with Toxoplasma gondii, a similar population emerged that limited T cell responses and was dependent on IFN-γ in the periphery but on IL-27 at mucosal sites. Transfer of Treg cells ameliorated the infection-induced pathology observed in Il27(-/-) mice, and this was dependent on their ability to produce IL-10. Microarray analysis revealed that Treg cells exposed to either IFN-γ or IL-27 have distinct transcriptional profiles. Thus, IFN-γ and IL-27 have different roles in Treg cell biology and IL-27 is a key cytokine that promotes the development of Treg cells specialized to control Th1 cell-mediated immunity at local sites of inflammation.

Pubmed ID: 22981537 RIS Download

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: AI084882
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI042334
  • Agency: NIAID NIH HHS, United States
    Id: R37-AI28724
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI055428
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007532
  • Agency: NIAID NIH HHS, United States
    Id: AI 071302
  • Agency: NIAID NIH HHS, United States
    Id: R37 AI028724
  • Agency: NIAID NIH HHS, United States
    Id: AI055428
  • Agency: NIAID NIH HHS, United States
    Id: R21-AI090234-01
  • Agency: NIAID NIH HHS, United States
    Id: P01 AI043620
  • Agency: NIAID NIH HHS, United States
    Id: R21 AI090234
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI061699
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI055400

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Gene Expression Profiling in Spinal Cord Injury (tool)

RRID:SCR_003260

Database which provides on-line searching of microarray datasets generated from rat spinal cord after contusion injury. Both the primary injury site and a site 5 mm distal to the injury site were assayed. Tissue was obtained from Long Evans rats subject to spinal cord contusion injury using the MASCIS impactor (formerly known as the NYU impactor). RNA expression was assayed at the site of injury and distal to the site of injury using the Affymetrix Rat Neuro U34 chip.

View all literature mentions

Bio X Cell (tool)

RRID:SCR_004997

Commercial supplier and developer of in vivo antibodies. Provides antibodies and antibody production services.

View all literature mentions

GenomeStudio (tool)

RRID:SCR_010973

Visualize and analyze data generated by all of Illumina''s platforms.

View all literature mentions